semaglutide cvot trial In patients with type 2 diabetes and atherosclerotic cardiovascular disease, tirzepatide was noninferior to dulaglutide with respect to major cardiovascular events. ⁣ ⁣ Read the full SURPASS-CVOT results and Research Summary SELECT Cardiovascular Trial Information |

Because they can cause similar symptoms or no symptoms at all they are often confused with one another

brought its anti-obesity drug Mounjaro to India on Thursday, marking the country's first treatment of its kind, with monthly costs ranging from 14,000 to 17,500

Surgery may also be recommended after several episodes of partial blockage that relieve themselves

This could trigger a greater inflammatory response and interfere with the absorption of the medication, leading to unwanted side effects

If tracking food and exercising intensely feels like punishment you are enduring rather than a routine you can sustain, continuous treatment at maintenance doses may prove less stressful overall